These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12415554)

  • 1. Monitoring the response to rTMS in depression with visual analog scales.
    Grunhaus L; Dolberg OT; Polak D; Dannon PN
    Hum Psychopharmacol; 2002 Oct; 17(7):349-52. PubMed ID: 12415554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive transcranial magnetic stimulation is effective following repeated courses in the treatment of major depressive disorder--a case report.
    Dannon PN; Grunhaus L
    Hum Psychopharmacol; 2003 Jun; 18(4):313-5. PubMed ID: 12766937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial.
    Fitzgerald PB; Brown TL; Marston NA; Daskalakis ZJ; De Castella A; Kulkarni J
    Arch Gen Psychiatry; 2003 Oct; 60(10):1002-8. PubMed ID: 14557145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: an open trial.
    Fabre I; Galinowski A; Oppenheim C; Gallarda T; Meder JF; De Montigny C; Olié JP; Poirier MF
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):833-42. PubMed ID: 15352140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression.
    Dell'Osso B; Mundo E; D'Urso N; Pozzoli S; Buoli M; Ciabatti M; Rosanova M; Massimini M; Bellina V; Mariotti M; Altamura AC
    Bipolar Disord; 2009 Feb; 11(1):76-81. PubMed ID: 19133969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression.
    Mogg A; Pluck G; Eranti SV; Landau S; Purvis R; Brown RG; Curtis V; Howard R; Philpot M; McLoughlin DM
    Psychol Med; 2008 Mar; 38(3):323-33. PubMed ID: 17935639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
    Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
    Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transcranial magnetic stimulation in depressed patients: a new antidepressive therapeutic principle? Presentation of a pilot trial].
    Koppi S; Conca A; Swoboda E; König P
    Wien Med Wochenschr; 1996; 146(3):49-54. PubMed ID: 8867273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of clinical response to transcranial magnetic stimulation for depression by baseline lateral visual-field stimulation.
    Schiffer F; Stinchfield Z; Pascual-Leone A
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Mar; 15(1):18-27. PubMed ID: 11877548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind sham controlled study of right prefrontal repetitive transcranial magnetic stimulation (rTMS): therapeutic and cognitive effect in medication free unipolar depression during 4 weeks.
    Januel D; Dumortier G; Verdon CM; Stamatiadis L; Saba G; Cabaret W; Benadhira R; Rocamora JF; Braha S; Kalalou K; Vicaut PE; Fermanian J
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):126-30. PubMed ID: 16242826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.
    Avery DH; Holtzheimer PE; Fawaz W; Russo J; Neumaier J; Dunner DL; Haynor DR; Claypoole KH; Wajdik C; Roy-Byrne P
    Biol Psychiatry; 2006 Jan; 59(2):187-94. PubMed ID: 16139808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of the Visual Analogue Scale for the assessment of depressive mood in cognitively impaired patients.
    Kertzman S; Aladjem Z; Milo R; Ben-Nahum Z; Birger M; Grinspan H; Weizman A; Kotler M
    Int J Geriatr Psychiatry; 2004 Aug; 19(8):789-96. PubMed ID: 15290703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional magnetic resonance imaging study of the effects of low frequency right prefrontal transcranial magnetic stimulation in depression.
    Fitzgerald PB; Sritharan A; Daskalakis ZJ; de Castella AR; Kulkarni J; Egan G
    J Clin Psychopharmacol; 2007 Oct; 27(5):488-92. PubMed ID: 17873682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
    Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reliability and validity of the Visual Analogue Scale (VAS) (author's transl)].
    Fähndrich E; Linden M
    Pharmacopsychiatria; 1982 May; 15(3):90-4. PubMed ID: 7100262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer than expected course of transcranial magnetic stimulation.
    Pridmore S; Poxon M; Chan C
    Aust N Z J Psychiatry; 1998 Feb; 32(1):140. PubMed ID: 9565198
    [No Abstract]   [Full Text] [Related]  

  • 20. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.